RCSB PDB: Search

1MFP \| pdb_00001mfp	Download File View File

E. coli Enoyl Reductase in complex with NAD and SB611113

Seefeld, M.A., Miller, W.H., Newlander, K.A., Burgess, W.J., DeWolf Jr., W.E., Elkins, P.A., Head, M.S., Jakas, D.R., Janson, C.A., Keller, P.M., Manley, P.J., Moore, T.D., Payne, D.J., Pearson, S., Polizzi, B.J., Qiu, X., Rittenhouse, S.F., Uzinskas, I.N., Wallis, N.G., Huffman, W.F.

(2003) J Med Chem 46: 1627-1635

Released	2003-05-06
Method	X-RAY DIFFRACTION 2.33 Å
Organisms	Escherichia coli
Macromolecule	enoyl-[acyl-carrier-protein] reductase [Nadh] (protein)
Unique Ligands	IDN, NAD, SO4

Explore in 3D

2VIN \| pdb_00002vin	Download File View File

Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator

Frederickson, M., Callaghan, O., Chessari, G., Congreve, M., Cowan, S.R., Matthews, J.E., McMenamin, R., Smith, D., Vinkovic, M., Wallis, N.G.

(2008) J Med Chem 51: 183

Released	2008-01-22
Method	X-RAY DIFFRACTION 1.9 Å
Organisms	Homo sapiens
Macromolecule	UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B (protein)
Unique Ligands	505, ACT, SO4

Explore in 3D

2VIO \| pdb_00002vio	Download File View File

Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator

Frederickson, M., Callaghan, O., Chessari, G., Congreve, M., Cowan, S.R., Matthews, J.E., McMenamin, R., Smith, D., Vinkovic, M., Wallis, N.G.

(2008) J Med Chem 51: 183

Released	2008-01-22
Method	X-RAY DIFFRACTION 1.8 Å
Organisms	Homo sapiens
Macromolecule	UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B (protein)
Unique Ligands	ACT, L1O

Explore in 3D

2VIP \| pdb_00002vip	Download File View File

Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator

Frederickson, M., Callaghan, O., Chessari, G., Congreve, M., Cowan, S.R., Matthews, J.E., McMenamin, R., Smith, D., Vinkovic, M., Wallis, N.G.

(2008) J Med Chem 51: 183

Released	2008-01-22
Method	X-RAY DIFFRACTION 1.72 Å
Organisms	Homo sapiens
Macromolecule	UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B (protein)
Unique Ligands	ACT, L1R, SO4

Explore in 3D

2VIQ \| pdb_00002viq	Download File View File

Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator

Frederickson, M., Callaghan, O., Chessari, G., Congreve, M., Cowan, S.R., Matthews, J.E., McMenamin, R., Smith, D., Vinkovic, M., Wallis, N.G.

(2008) J Med Chem 51: 183

Released	2008-01-22
Method	X-RAY DIFFRACTION 2 Å
Organisms	Homo sapiens
Macromolecule	UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B (protein)
Unique Ligands	ACT, D55

Explore in 3D

2VIV \| pdb_00002viv	Download File View File

Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator

Frederickson, M., Callaghan, O., Chessari, G., Congreve, M., Cowan, S.R., Matthews, J.E., McMenamin, R., Smith, D., Vinkovic, M., Wallis, N.G.

(2008) J Med Chem 51: 183

Released	2008-01-22
Method	X-RAY DIFFRACTION 1.72 Å
Organisms	Homo sapiens
Macromolecule	UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B (protein)
Unique Ligands	ACT, VG2

Explore in 3D

2VIW \| pdb_00002viw	Download File View File

Fragment-Based Discovery of Mexiletine Derivatives as Orally Bioavailable Inhibitors of Urokinase-Type Plasminogen Activator

Frederickson, M., Callaghan, O., Chessari, G., Congreve, M., Cowan, S.R., Matthews, J.E., McMenamin, R., Smith, D., Vinkovic, M., Wallis, N.G.

(2008) J Med Chem 51: 183

Released	2008-01-22
Method	X-RAY DIFFRACTION 2.05 Å
Organisms	Homo sapiens
Macromolecule	UROKINASE-TYPE PLASMINOGEN ACTIVATOR CHAIN B (protein)
Unique Ligands	ACT, D56

Explore in 3D

5OQW \| pdb_00005oqw	Download File View File

XIAP in complex with small molecule

Williams, P.A.

(2018) Mol Cancer Ther 17: 1381-1391

Released	2018-06-27
Method	X-RAY DIFFRACTION 2.31 Å
Organisms	Homo sapiens
Macromolecule	E3 ubiquitin-protein ligase XIAP (protein)
Unique Ligands	A4E, NA, ZN

Explore in 3D

6G8X \| pdb_00006g8x	Download File View File

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

O'Reilly, M.

(2018) J Med Chem 61: 4978-4992

Released	2018-05-30
Method	X-RAY DIFFRACTION 1.76 Å
Organisms	Homo sapiens
Macromolecule	Mitogen-activated protein kinase 1 (protein)
Unique Ligands	EQT, SO4

Explore in 3D

6G91 \| pdb_00006g91	Download File View File

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

O'Reilly, M.

(2018) J Med Chem 61: 4978-4992

Released	2018-05-30
Method	X-RAY DIFFRACTION 1.8 Å
Organisms	Homo sapiens
Macromolecule	Mitogen-activated protein kinase 1 (protein)
Unique Ligands	EQW, SO4

Explore in 3D

6G92 \| pdb_00006g92	Download File View File

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

O'Reilly, M.

(2018) J Med Chem 61: 4978-4992

Released	2018-05-30
Method	X-RAY DIFFRACTION 1.99 Å
Organisms	Homo sapiens
Macromolecule	Mitogen-activated protein kinase 1 (protein)
Unique Ligands	ERZ, SO4

Explore in 3D

6G93 \| pdb_00006g93	Download File View File

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

O'Reilly, M.

(2018) J Med Chem 61: 4978-4992

Released	2018-05-30
Method	X-RAY DIFFRACTION 1.67 Å
Organisms	Homo sapiens
Macromolecule	Mitogen-activated protein kinase 1 (protein)
Unique Ligands	EU2, SO4

Explore in 3D

6G97 \| pdb_00006g97	Download File View File

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

O'Reilly, M.

(2018) J Med Chem 61: 4978-4992

Released	2018-05-30
Method	X-RAY DIFFRACTION 1.9 Å
Organisms	Homo sapiens
Macromolecule	Mitogen-activated protein kinase 1 (protein)
Unique Ligands	EQZ, SO4

Explore in 3D

6G9A \| pdb_00006g9a	Download File View File

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

O'Reilly, M.

(2018) J Med Chem 61: 4978-4992

Released	2018-05-30
Method	X-RAY DIFFRACTION 1.91 Å
Organisms	Homo sapiens
Macromolecule	Mitogen-activated protein kinase 1 (protein)
Unique Ligands	ESQ, SO4

Explore in 3D

6G9D \| pdb_00006g9d	Download File View File

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

O'Reilly, M.

(2018) J Med Chem 61: 4978-4992

Released	2018-05-30
Method	X-RAY DIFFRACTION 1.8 Å
Organisms	Homo sapiens
Macromolecule	Mitogen-activated protein kinase 1 (protein)
Unique Ligands	ER8, SO4

Explore in 3D

6G9H \| pdb_00006g9h	Download File View File

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

O'Reilly, M.

(2018) J Med Chem 61: 4978-4992

Released	2018-05-30
Method	X-RAY DIFFRACTION 1.73 Å
Organisms	Homo sapiens
Macromolecule	Mitogen-activated protein kinase 1 (protein)
Unique Ligands	ERW, SO4

Explore in 3D

6G9J \| pdb_00006g9j	Download File View File

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

O'Reilly, M.

(2018) J Med Chem 61: 4978-4992

Released	2018-05-30
Method	X-RAY DIFFRACTION 1.98 Å
Organisms	Homo sapiens
Macromolecule	Mitogen-activated protein kinase 1 (protein)
Unique Ligands	ERK, SO4

Explore in 3D

6G9K \| pdb_00006g9k	Download File View File

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

O'Reilly, M.

(2018) J Med Chem 61: 4978-4992

Released	2018-05-30
Method	X-RAY DIFFRACTION 1.94 Å
Organisms	Homo sapiens
Macromolecule	Mitogen-activated protein kinase 1 (protein)
Unique Ligands	ESK, SO4

Explore in 3D

6G9M \| pdb_00006g9m	Download File View File

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

O'Reilly, M.

(2018) J Med Chem 61: 4978-4992

Released	2018-05-30
Method	X-RAY DIFFRACTION 1.86 Å
Organisms	Homo sapiens
Macromolecule	Mitogen-activated protein kinase 1 (protein)
Unique Ligands	ESW, SO4

Explore in 3D

6G9N \| pdb_00006g9n	Download File View File

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

O'Reilly, M.

(2018) J Med Chem 61: 4978-4992

Released	2018-05-30
Method	X-RAY DIFFRACTION 1.76 Å
Organisms	Homo sapiens
Macromolecule	Mitogen-activated protein kinase 1 (protein)
Unique Ligands	ESN, SO4

Explore in 3D

6GDM \| pdb_00006gdm	Download File View File

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

O'Reilly, M.

(2018) J Med Chem 61: 4978-4992

Released	2018-05-30
Method	X-RAY DIFFRACTION 1.91 Å
Organisms	Homo sapiens
Macromolecule	Mitogen-activated protein kinase 1 (protein)
Unique Ligands	DMS, F3Z, SO4

Explore in 3D

6GDQ \| pdb_00006gdq	Download File View File

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

O'Reilly, M.

(2018) J Med Chem 61: 4978-4992

Released	2018-05-30
Method	X-RAY DIFFRACTION 1.86 Å
Organisms	Homo sapiens
Macromolecule	Mitogen-activated protein kinase 1 (protein)
Unique Ligands	DMS, EVK, SO4

Explore in 3D

6GE0 \| pdb_00006ge0	Download File View File

Fragment-based discovery of a highly potent, orally bioavailable inhibitor which modulates the phosphorylation and catalytic activity of ERK1/2

O'Reilly, M.

(2018) J Med Chem 61: 4978-4992

Released	2018-05-30
Method	X-RAY DIFFRACTION 1.82 Å
Organisms	Homo sapiens
Macromolecule	Mitogen-activated protein kinase 1 (protein)
Unique Ligands	DMS, EVQ, SO4

Explore in 3D

7AUV \| pdb_00007auv	Download File View File

The structure of ERK2 in complex with dual inhibitor ASTX029

O'Reilly, M.

(2021) Mol Cancer Ther 20: 1757-1768

Released	2021-10-06
Method	X-RAY DIFFRACTION 1.76 Å
Organisms	Homo sapiens
Macromolecule	Mitogen-activated protein kinase 1 (protein)
Unique Ligands	DMS, RYW, SO4

Explore in 3D

7NQQ \| pdb_00007nqq	Download File View File

Discovery of ASTX029, a clinical candidate which modulates the phosphorylation and catalytic activity of ERK1/2

O'Reilly, M.

(2021) J Med Chem 64: 12286-12303

Released	2021-10-06
Method	X-RAY DIFFRACTION 1.943 Å
Organisms	Homo sapiens
Macromolecule	Mitogen-activated protein kinase 1 (protein)
Unique Ligands	DMS, SO4, UMN

Prepare Data

Validate Data

Deposit Data

Help and Resources

Structure Determination Methodology

Scientific Name of Source Organism

Taxonomy

Experimental Method

Polymer Entity Type

Refinement Resolution (Å)

Release Date

Enzyme Classification Name

Symmetry Type

SCOP Classification

1MFP | pdb_00001mfp

2VIN | pdb_00002vin

2VIO | pdb_00002vio

2VIP | pdb_00002vip

2VIQ | pdb_00002viq

2VIV | pdb_00002viv

2VIW | pdb_00002viw

5OQW | pdb_00005oqw

6G8X | pdb_00006g8x

6G91 | pdb_00006g91

6G92 | pdb_00006g92

6G93 | pdb_00006g93

6G97 | pdb_00006g97

6G9A | pdb_00006g9a

6G9D | pdb_00006g9d

6G9H | pdb_00006g9h

6G9J | pdb_00006g9j

6G9K | pdb_00006g9k

6G9M | pdb_00006g9m

6G9N | pdb_00006g9n

6GDM | pdb_00006gdm

6GDQ | pdb_00006gdq

6GE0 | pdb_00006ge0

7AUV | pdb_00007auv

7NQQ | pdb_00007nqq